Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Longitudinal plasma neurofilament light chain and patient-reported outcomes as complementary markers of vincristine-associated peripheral neuropathy in adults with lymphoma: a cohort study.

medRxiv : the preprint server for health sciences·2026
Same author

MRD-negativity by PBMCs and ctDNA confirms deep and durable responses following epcoritamab monotherapy in R/R FL.

Blood advances·2026
Same author

Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.

Blood advances·2026
Same author

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

Blood advances·2026
Same author

Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Impact of baseline osseous involvement on outcomes in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia.

Blood neoplasia·2026

相关实验视频

Updated: Jul 11, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.2K

NCCN指南®洞察力:B细胞淋巴瘤,版本6.2023

Andrew D Zelenetz1, Leo I Gordon2, Jeremy S Abramson3

  • 1Memorial Sloan Kettering Cancer Center.

Journal of the National Comprehensive Cancer Network : JNCCN
|November 7, 2023
PubMed
概括

新型向疗法,包括布鲁顿疗法.

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.1K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.1K

相关实验视频

Last Updated: Jul 11, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.2K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.1K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.1K

科学领域:

  • 血液学和瘤学研究
  • 免疫治疗是一种免疫疗法.
  • 临床指南 临床指南

背景情况:

  • 复发性/耐药性B细胞淋巴瘤存在重大治疗挑战.
  • 传统的治疗模式正在被新型治疗剂迅速更新.
  • 膜细胞淋巴瘤 (MCL),毛囊性淋巴瘤 (FL) 和扩散性大B细胞淋巴瘤 (DLBCL) 是关键的亚型.

研究的目的:

  • 总结一下针对B细胞淋巴瘤的向治疗的最新进展.
  • 要突出FL,DLBCL和MCL的NCCN指南的更新.
  • 提供对复发性/耐药性疾病不断变化的治疗环境的见解.

主要方法:

  • 对包括小分子抑制剂,抗体药物合物和细胞疗法在内的新型向疗法的审查.
  • 分析布鲁顿氨酸激酶 (BTK) 抑制剂在演变中的作用.
  • 评估针对CD19的疗法,如CAR T细胞和双特异性T细胞参与剂.

主要成果:

  • 向疗法已经改变了复发/耐药B细胞淋巴瘤的治疗方法.
  • 在MCL中,BTK抑制剂越来越重要,无论是前线还是复发/耐药.
  • 卡尔T细胞疗法和双特异性T细胞参与剂为复发性/耐药性FL,DLBCL和MCL提供了新的选择.

结论:

  • 对NCCN指南的重大更新反映了B细胞淋巴瘤治疗的快速进展.
  • 新型免疫疗法和向药物正在成为标准的护理.
  • 这些进展为复发/耐药B细胞淋巴瘤患者提供了更好的治疗结果.